Orchid Pharma Limited (ORCHPHARMA) Stock Statistics & Valuation Metrics

Orchid Pharma Limited has a market cap or net worth of ₹37.99B. The enterprise value is ₹39.06B.

Orchid Pharma Limited has 50,719,105 shares outstanding. The number of shares has decreased by -2.65% in one year.

Orchid Pharma Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 17.80%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Orchid Pharma Limited had revenue of 9.22B and earned 996.57M in profits. Earnings per share was 19.65.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Orchid Pharma Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―

Orchid Pharma Limited upcoming earnings date is Aug 7, 2025, TBA (Confirmed).

Orchid Pharma Limited as a current ratio of 2.83, with Debt / Equity ratio of 13.78%

In the past 12 months, Orchid Pharma Limited has paid -1.94M in taxes.

Orchid Pharma Limited EV to EBITDA ratio is 28.51, with an EV/FCF ratio of -31.51.

Orchid Pharma Limited has ₹2.44B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹2.44B billion.

Gross margin is 40.97%, with operating margin of 27.85%, and net profit margin of 10.81%.

The average price target for Orchid Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―